A new lung detection machine at CHRISTUS St. Frances Cabrini Hospital is helping doctors identify lung issues earlier.

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...

Multimodal model delivers personalized risk estimates and clinician-adjustable insights to support surgical decisions.

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...

Rectal cancer deaths among millennials under 45 are rising 2–3 times faster than colon cancer. Doctors urge early symptom ...

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

UB and Roswell Park researchers created MIRACLE, an AI tool that combines clinical data, CT imaging and LLM insights to ...

A nanophotonic biochip combined with AI detects microRNA biomarkers in 20 minutes with high accuracy, enabling rapid, ...